Immunostaining for ubiquitin: Efficient pretreatment [2]

Neuropathology and Applied Neurobiology

Volumn 29, Issue 2, 2003, Pages 174-177

  Kovacs, G G ^a   Flicker, H ^a   Budka, H ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; ANTIBODY; BUFFER; CITRIC ACID; FORMIC ACID; MONOCLONAL ANTIBODY; PARAFFIN; POLYCLONAL ANTIBODY; PRION PROTEIN; SODIUM CHLORIDE; UBIQUITIN;

ALZHEIMER DISEASE; ANTIBODY AFFINITY; ANTIBODY LABELING; ANTIGEN PRESENTATION; ANTIGEN RETRIEVAL; BRAIN TISSUE; CELL DEATH; CENTRAL NERVOUS SYSTEM DISEASE; CEREBELLUM; CINGULATE GYRUS; CREUTZFELDT JAKOB DISEASE; CYTOPLASM; DEGENERATIVE DISEASE; DIFFUSE LEWY BODY DISEASE; DYSTROPHY; HIPPOCAMPUS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KURU; LETTER; MESENCEPHALON; METHODOLOGY; MICROWAVE OVEN; MOTOR NEURON DISEASE; NEURITE; NEUROPATHOLOGY; NEUROPIL; PARKINSON DISEASE; PATHOLOGY; PH; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN DEGRADATION; RELIABILITY; SCREENING; SIGNAL NOISE RATIO; SPINAL CORD; TEMPORAL CORTEX;

HUMANS; IMMUNOHISTOCHEMISTRY; NEURODEGENERATIVE DISEASES; STAINING AND LABELING; UBIQUITIN;

EID: 0037385562     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2990.2003.00433.x     Document Type: Letter

References (14)

1. Carrell RW, Lomas DA. Conformational disease. Lancet 1997; 350: 134-8
2. Cammarata S, Tabaton M. Ubiquitin-reactive axons have a widespread distribution and are unrelated to prion protein plaques in Creutzfeldt-Jakob disease. J Neurol Sci 1992; 110: 32-6
3. Giordana MT, Richiardi P, Trevisan E, Boghi A, Palmucci L. Abnormal ubiquitination of axons in normally myelinated white matter in multiple sclerosis brain. Neuropathol Appl Neurobiol 2002; 28: 35-41
4. Halliday G, Ng T, Rodriguez M, Harding A, Blumbergs P, Evans W, Fabian V, Fryer J, Gonzales M, Harper C, Kalnins R, Masters CL, McLean C, Milder DG, Pamphlett R, Scott G, Tannenberg A, Kril J. Consensus neuropathological diagnosis of common dementia syndromes: testing and standardising the use of multiple diagnostic criteria. Acta Neuropathol 2002; 104: 72-8
5. Hershko A. Ubiquitin-mediated protein degradation. J Biol Chem 1988; 263: 15237-40
6. Ironside JW, McCardle L, Hayward PA, Bell JE. Ubiquitin immunocytochemistry in human spongiform encephalopathies. Neuropathol Appl Neurobiol 1993; 19: 134-40
7. Kovacs GG, László L. The message of ubiquitin immunohistochemistry in conformational neurodegenerative diseases. In Conformational Diseases - A Compendium. Eds B Solomon. A Taraboulos, E Katchalski-Katzir. Jerusalem: Bialik Institute, 2001; 249-58
8. Layfield R, Alban A, Mayer RJ, Lowe J. The ubiquitin protein catabolic disorders. Neuropathol Appl Neurobiol 2001; 27: 171-9
9. Lowe J. Establishing a pathological diagnosis in degenerative dementias. Brain Pathol 1998; 8: 403-6
10. Lowe J, Mayer RJ, Landon M. Ubiquitin in neurodegenerative diseases. Brain Pathol 1993; 3: 55-65
11. Lowe J, Blanchard A, Morrell K, Lennox G, Reynolds L, Billett M, Landon M, Mayer RJ. Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and mallory bodies in alcoholic liver disease. J Pathol 1988; 155: 9-15
12. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996; 47: 1113-24
13. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41: 479-86
14. Suenaga T, Hirano A, Llena JF, Ksiezak-Reding H, Yen SH, Dickson DW, Ubiquitin immunoreactivity in kuru plaques in Creutzfeldt-Jakob disease. Ann Neurol 1990; 28: 174-7